Norgestimate - CAS 35189-28-7
Catalog number: 35189-28-7
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
Molecular Weight:
Norgestimate is a form of progesterone used with estradiol to treat the symptoms of menopause.
Publictions citing BOC Sciences Products
  • >> More
White Crystalline Solid
[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate;
Soluble in DMSO
Store at -20 °C
Estrogen receptor agonists; Progesterone receptor agonists
Quality Standard:
Enterprise standard/USP
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly.
Boiling Point:
497.9ºC at 760mmHg
Melting Point:
214-216 °C
Canonical SMILES:
Current Developer:
Johnson & Johnson
1.Simultaneous determination of estrogens (ethinylestradiol and norgestimate) concentrations in human and bovine serum albumin by use of fluorescence spectroscopy and multivariate regression analysis.
Hordge LN1, McDaniel KL1, Jones DD1, Fakayode SO2. Talanta. 2016 May 15;152:401-9. doi: 10.1016/j.talanta.2016.02.034. Epub 2016 Feb 17.
The endocrine disruption property of estrogens necessitates the immediate need for effective monitoring and development of analytical protocols for their analyses in biological and human specimens. This study explores the first combined utility of a steady-state fluorescence spectroscopy and multivariate partial-least-square (PLS) regression analysis for the simultaneous determination of two estrogens (17α-ethinylestradiol (EE) and norgestimate (NOR)) concentrations in bovine serum albumin (BSA) and human serum albumin (HSA) samples. The influence of EE and NOR concentrations and temperature on the emission spectra of EE-HSA EE-BSA, NOR-HSA, and NOR-BSA complexes was also investigated. The binding of EE with HSA and BSA resulted in increase in emission characteristics of HSA and BSA and a significant blue spectra shift. In contrast, the interaction of NOR with HSA and BSA quenched the emission characteristics of HSA and BSA. The observed emission spectral shifts preclude the effective use of traditional univariate regression analysis of fluorescent data for the determination of EE and NOR concentrations in HSA and BSA samples.
2.Hypercoagulability in adolescent girls on oral contraceptives-global coagulation profile and estrogen receptor polymorphisms.
Zia A1, Callaghan MU2, Callaghan JH3, Sawni A4, Bartlett H5, Backos A5, Marshall S5, Chitlur M2, Rajpurkar M2. Am J Hematol. 2015 Aug;90(8):725-31. doi: 10.1002/ajh.24064.
Oral contraceptive (OCP) induced changes on coagulation are complex with high inter-individual variability. The precise reason for differences in this variability is unknown. We hypothesized that global coagulation assays better delineate these changes and variability in hypercoagulability may be the result of differences in estrogen metabolism and thrombophilia. Fifty-two adolescents initiating OCPs were prospectively enrolled; 33 subjects completed the study. Samples were analyzed prior to and after OCPs for procoagulant and anticoagulant factor activities and thrombin generation (TG) +/-thrombomodulin. Participants were genotyped for common thrombophilia and estrogen receptor-α (ESR-α) single nucleotide polymorphisms (SNPs). SNP genotypes were compared to coagulation parameters; TG parameters and differences pre and post OCPs were examined. At baseline, a striking finding was elevated FVIII levels. FVL was absent in all and F2 G20210A was present in one participant.
3.Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.
Vinogradova Y1, Coupland C2, Hippisley-Cox J2. BMJ. 2015 May 26;350:h2135. doi: 10.1136/bmj.h2135.
OBJECTIVE: To investigate the association between use of combined oral contraceptives and risk of venous thromboembolism, taking the type of progestogen into account.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products

CAS 58-96-8 Uridine

(CAS: 58-96-8)

Uridine is a nucleoside, contains a uracil attached to a ribose ring via a β-N1-glycosidic bond.

CAS 68370-47-8 Micheliolide

(CAS: 68370-47-8)

Micheliolide could effectively attenuate the high glucose-stimulated activation of NF-κB, the degradation of IκBα, and the expression of MCP-1, TGF-β1 and FN in...

(CAS: 1054629-49-0)

AZD-4694 is a bio-active chemical compound and is used as a diagnostic imaging agent. It was developed by AstraZeneca.

CAS 19130-96-2 Deoxynojirimycin

(CAS: 19130-96-2)

Deoxynojirimycin inhibits mammalian glucosidase 1. As well, it inhibits intestinal and lysosmal alpha-glucosidases, beta-glucosidase from sweet almonds, pancrea...

CAS 149845-07-8 Tiludronic acid disodium salt

Tiludronic acid disodium salt
(CAS: 149845-07-8)

The disodium salt form of Tiludronic acid which has been found to be a biphosphonate bone resorption inhibitor and could be used against osteitis deformans.

CAS 1216897-16-3 2-(5-fluoropentyl)-2-methylmalonic acid

2-(5-fluoropentyl)-2-methylmalonic acid
(CAS: 1216897-16-3)

This molecular is a [18F] PET (positron emission tomography) radiotracer. It can accumulate in cells presenting apoptosis-specific membrane alterations. ML-10 a...

CAS 135-16-0 L-Tetrahydrofolic Acid

L-Tetrahydrofolic Acid
(CAS: 135-16-0)

Tetrahydrofolic acid is a folic acid derivative. It is a cofactor in many bio-reactions, especially in the metabolism of amino acids and nucleic acids.

CP74725 sodium salt
(CAS: 111477-48-6)

CP74725 sodium salt is a bio-active chemical compound.

(CAS: 220551-92-8)

DAA-1106, with anxiolytic effects in mice, is a selective ligand for peripheral benzodiazepine receptor (PBR) and a selective agonist at the peripheral benzodia...

CAS 69-65-8 D-Mannitol

(CAS: 69-65-8)

D-Mannitol inhibits renal tubular reabsorption of sodium, chloride, and other solutes.It also inhibits neutrophil apoptosis.

CAS 148554-65-8 seco Rapamycin Sodium Salt

seco Rapamycin Sodium Salt
(CAS: 148554-65-8)

Seco-rapamycin is the first in vivo open-ring metabolite of rapamycin which is a natural macrolide immunosuppressant. Seco-rapamycin inhibits the ChT-L (D) and ...

CAS 4382-63-2 PFK15

(CAS: 4382-63-2)

PFK15 is a potent and selective 6-phosphofructo-2-kinase (PFKFB3) with IC50 of 207 nM.

CAS 1035979-44-2 P005672 HCl

P005672 HCl
(CAS: 1035979-44-2)

P005672 HCl is a novel, tetracycline-substituted, narrow-spectrum antibiotic compound used for treatment of bacterial infections and neoplasms. It is developed ...

(CAS: 923562-23-6)

STK321130 is potent FLT3 inhibitor with IC50 value of less than 1 μM.

(CAS: 1050477-31-0)

Finerenone is a non-steroidal antimineralocorticoid. It has less relative affinity to other steroid hormone receptors than currently available, which should res...

(CAS: 149365-62-8)

TPY-5628, a pyrrole derivative, has been found to be commonly used in sorts of chemical areas like anticancer drugs as an significant intermediate.

CAS 42228-92-2 Acivicin

(CAS: 42228-92-2)

Acivicin is a glutamine analog that irreversibly inhibits glutamine-dependent amidotransferases involved in nucleotide and amino acid biosynthesis (Kis = 10 and...

CAS 201530-41-8 Deferasirox

(CAS: 201530-41-8)

Deferasirox effectively chelates iron from Rhizopus oryzae and demonstrates cidal activity in vitro against 28 of 29 clinical isolates of Mucorales at concentra...

CAS 106635-80-7 Tafenoquine

(CAS: 106635-80-7)

Tafenoquine is an oral active and an 8-aminoquinoline antimalaria drug. It is being investigated as a potential treatment for malaria, as well as for malaria pr...

CAS 188627-80-7 Eptifibatide

(CAS: 188627-80-7)

A Arginin-glycin-aspartat-mimetic, reversibly binds to platelets to reduce the risk of cardiac ischemic events.

Chemical Structure

CAS 35189-28-7 Norgestimate

Quick Inquiry

Verification code

Featured Items